Hartalega Holdings Berhad: Segment Analysis

Hartalega Holdings Berhad (Hartalega) is primarily engaged in the production in the manufacturing and sale of latex gloves. It is recognized as a leading nitrile glove producer with a significant manufacturing capacity, producing billions of gloves annually. The company serves the healthcare industry by providing protective gloves for healthcare practitioners and the people they care for. Hartalega is committed to innovation and utilizes advanced proprietary manufacturing technology to ensure product quality and operational efficiency. The company operates the fastest production lines in the industry, capable of producing more than 45,000 gloves per hour.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Hartalega has continued to strengthen its commitment to R&D to drive innovation and maintain competitiveness in the glove industry. The R&D team played a pivotal role in delivering technological progress, completing 30% of sustainability-focused innovation projects during the year, which included initiatives aimed at reducing energy consumption, optimizing water and chemical usage, and further enhancing the BDG Biodegradable Glove. The company also introduced several new products such as latex and nitrile gloves with colloidal oatmeal, upgraded biodegradable gloves, Goodpac+ with AMG, and chemical-resistant nitrile gloves, reflecting its commitment to innovation, safety, comfort and sustainability. In FY2025, Hartalega submitted two new patent applications, bringing its total patents to 10, while continuing to expand its technology-driven product portfolio aligned with evolving global healthcare needs. In FY2025, the company spent MYR9.6 million on R&D, which accounted for 0.4% of the company’s revenue.